Skip to content
Toggle Navigation
HOME
ABOUT
TRIALS
Hemorrhagic Cystitis Clinical Trial
Radiation Cystitis Patient Registry
MANAGEMENT
PUBLICATIONS
INVESTORS
Corporate Overview
SEC Filings
Press Releases
Stock Quote
Events & Presentations
Corporate Governance
FAQ’s
Investor Relations Contact
Recent News
Radiation Cystitis Registry
Press Releases
Lipella Pharmaceuticals, Inc
2023-02-07T19:09:45+00:00
Investors: Press Releases
Press Releases
Investors
Corporate Overview
SEC Filings
Press Releases
Stock Quote
Events & Presentations
Corporate Governance
FAQ’s
Investor Relations Contact
Close Sliding Bar Area
Recent Posts
Lipella Pharma Sees Positive Results for LP-10 Phase 2a Trial
Lipella Pharmaceuticals Announces Pricing of Initial Public Offering of Common Stock
Announcing Radiation (and Hemorrhagic) Cystitis Patient Registry
Lipella Pharmaceuticals Announces Successful Completion of Pre-IND Type B FDA Meeting Regarding Oral Lichen Planus Drug Candidate
Bladder Health Foundation Launches Patient Registry for Survivors of Pelvic Radiation Therapy
Lipella Pharmaceuticals, Inc.
Phone:
412-894-1853
Email:
Get In Touch Via Email
Reach Out
Investors
Corporate Overview
SEC Filings
Press Releases
Stock Quote
Events & Presentations
Corporate Governance
FAQ’s
Investor Relations Contact
Page load link
Go to Top
Reach Out